Retrospective Study of Acute Kidney Injury Incidence in Patients with Newly Diagnosed Acute Promyelocytic Leukemia

References

• Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the haemacare project. Blood. 2010;116(19):3724–3734. doi:10.1182/blood-2010-05-28263220664057
   PubMed Web of Science ®Google Scholar
• Sanz MA, Lo-Coco F. Modern approaches to treating acute promyelocytic leukemia. Clin Infect Dis. 2011;29(5):495–503. doi:10.1200/JCO.2010.32.1067
   Web of Science ®Google Scholar
• Montesinos P, Bergua JM, Vellenga E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009;113(4):775–783. doi:10.1182/blood-2008-07-16861718945964
   PubMed Web of Science ®Google Scholar
• Lehmann S, Ravn A, Carlsson L, et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia. 2011;25(7):1128–1134. doi:10.1038/leu.2011.7821502956
   PubMed Web of Science ®Google Scholar
• Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017;92(1):37–46. doi:10.1016/j.kint.2016.11.02928318633
   PubMed Web of Science ®Google Scholar
• Tallman MS, Andersen JW, Schiffer CA, et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood. 2000;95:90–95.10607690
   PubMed Web of Science ®Google Scholar
• Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370. doi:10.1681/ASN.200409074016177006
   PubMed Web of Science ®Google Scholar
• Lahoti A, Kantarjian H, Salahudeen AK, et al. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer. 2010;116(17):4063–4068. doi:10.1002/cncr.2530620564156
   PubMed Web of Science ®Google Scholar
• Canet E, Zafrani L, Lambert J, et al. Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS One. 2013;8(2):e55870. doi:10.1371/journal.pone.005587023457485
   PubMed Web of Science ®Google Scholar
• Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the prevAKI randomized controlled trial. Intensive Care Med. 2017;43(11):1551–1561. doi:10.1007/s00134-016-4670-328110412
   PubMed Web of Science ®Google Scholar
• Summary of recommendation statements. Kidney Int Suppl. 2012;2(1):8–12. doi:10.1038/kisup.2012.7
   PubMed Web of Science ®Google Scholar
• Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793–1800. doi:10.1097/00003246-199811000-000169824069
   PubMed Web of Science ®Google Scholar
• Sanz MA, Montesinos P. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia. Blood. 2014;123(18):2777–2782. doi:10.1182/blood-2013-10-51264024627526
   PubMed Web of Science ®Google Scholar
• Luciano RL, Brewster UC. Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis. 2014;21(1):27–35. doi:10.1053/j.ackd.2013.07.00424359984
   PubMed Web of Science ®Google Scholar
• Di Micco L, Mirenghi F, Morelli E, De Simone E. Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report. G Ital Nefrol. 2019;36(4).
   PubMedGoogle Scholar
• Seylanova N, Crichton S, Zhang J, Fisher R, Ostermann M. Acute kidney injury in critically ill cancer patients is associated with mortality: a retrospective analysis. PLoS One. 2020;15(5):e0232370. doi:10.1371/journal.pone.023237032437362
   PubMed Web of Science ®Google Scholar
• Chamoun K, Kantarjian HM, Wang X, et al. Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia. Cancer. 2019;125(18):3219–3224. doi:10.1002/cncr.3219631150121
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285–292. doi:10.1093/cid/cir03421217178
   PubMed Web of Science ®Google Scholar
• Wilson FP, Berns JS. Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis. 2014;21(1):18–26. doi:10.1053/j.ackd.2013.07.00124359983
   PubMed Web of Science ®Google Scholar
• Filippone EJ, Kraft WK, Farber JL. The nephrotoxicity of vancomycin. Clin Pharmacol Ther. 2017;102(3):459–469. doi:10.1002/cpt.72628474732
   PubMed Web of Science ®Google Scholar
• Okada N, Chuma M, Azuma M, et al. Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study. Eur J Clin Pharmacol. 2019;75(12):1695–1704. doi:10.1007/s00228-019-02756-431511938
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Tokimatsu I, Morinaga Y, et al. A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy. Clin Chim Acta. 2015;440:183–187. doi:10.1016/j.cca.2014.11.02725476135
   PubMed Web of Science ®Google Scholar
• Chastain DB, Wheeler S, Franco-Paredes C, Olubajo B, Hawkins WA. Evaluating guideline adherence regarding empirical vancomycin use in patients with neutropenic fever. Clin Infect Dis. 2018;69:88–93.
   Google Scholar
• Melling PA, Noto MJ, Rice TW, Semler MW, Stollings JL. Time to first culture positivity among critically ill adults with methicillin-resistant staphylococcus aureus growth in respiratory or blood cultures. Ann Pharmacother. 2020;54(2):131–137. doi:10.1177/106002801987793731544471
   PubMed Web of Science ®Google Scholar
• Sinha Ray A, Haikal A, Hammoud KA, Yu AS. Vancomycin and the risk of AKI: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2016;11(12):2132–2140. doi:10.2215/CJN.0592061627895134
   PubMed Web of Science ®Google Scholar
• Park JH, Qiao B, Panageas KS, et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 2011;118(5):1248–1254. doi:10.1182/blood-2011-04-34643721653939
   PubMed Web of Science ®Google Scholar